The Fly

Pacific Biosciences 17.5M share Spot Secondary priced at $10.00

The deal size was increased to $175M in common stock from $150M in common stock and priced at the low-end of the $10.00-$10.25 range. Goldman Sachs, Morgan Stanley, Cowen and Allen & Co. acted as joint book running managers for the offering.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on PACB:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More